Clinical Trial Update: Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial investigates effervescent calcium-magnesium citrate as a potential therapy for chronic kidney disease stage V; currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Effervescent Calcium-Magnesium Citrate

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: CKD Stage 5 | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING